Diethylene glycol bis(methacrylate)
- Oxydi-2,1-ethanediyl bismethacrylate
- Diethylene glycol dimethacrylate
- Oxydiethylene methacrylate
- TGM 2
Colorless liquid. Ester-like odor.
Crosslinked acrylicvinyl resin comonomer.
Registry Numbers and Inventories.
S 26 28
Japan ENCS (MITI)
Boiling point, °C
82 - 84 (0.04 torr)
1.07 g/cm3 (20 C)
1.4571 (25 C)
Hazards and Protection.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Suitable protective clothing and self-contained resp protective apparatus should be available for use of those who may have to rescue persons overcome by fumes.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Strong oxidizing agents.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Central nervous system depressant effects, including drowsiness, headache, progressive obtundation and coma have preceded death. Drowsiness is usually delayed approximately 24 hours after ingestion. Meningismus, cerebral edema and hemorrhage, and neuropathies have been reported. No human data were found at the time of this review with the exception of 1 case of menstrual irregularities from exposure to several acrylates. Animal studies at the time of this review did not show conclusive evidence of fetotoxicity or teratogenicity.
Common initial symptoms are heartburn, followed by nausea and abdominal cramps, vomiting and occasionally diarrhea. Later symptoms include back pain and severe abdominal pain.
Death normally occurs from sudden cardiorespiratory arrest. Pulmonary edema may develop. Tachypnea may occur secondary to acidosis.
Skin irritation, necrosis, and allergic contact dermatitis have been reported in workers.
Administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists. Some chemicals can produce systemic poisoning by absorption through intact skin. Carefully observe patients with dermal exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.